结直肠癌是主要癌症致死性疾病。虽然手术和放化疗对其有一定的疗效,但仍然有很多患者因癌细胞转移而死亡。新近的研究证明,生物靶向药物联合化疗可为那些已经丧失手术机会的患者重新提供可获得手术治疗的机会,延长患者术后生存时间和提高生存质量。现报告结肠癌术后伴肝肺多脏器转移应用尼妥珠单抗联合化疗1例,治疗后转移病灶明显缩小,症状迅速得到缓解控制。患者男,74岁。2002年诊断为结肠癌,经手术和化疗,原 Colorectal cancer is the leading cancer fatal disease. Although surgery and radiotherapy and chemotherapy have a certain effect on it, there are still many patients died of cancer cell metastasis. Recent research shows that the combination of bio-targeted drugs and chemotherapy can provide patients who have lost their chances of surgery with the opportunity to obtain surgical treatment, prolong the survival time of patients and improve the quality of life. Now report the colon cancer with liver and lung multiple organ metastasis after application of nimotuzumab combined with chemotherapy in 1 case, the treatment of metastatic lesions was significantly reduced, the symptoms were quickly eased control. Male patient, 74 years old. 2002 diagnosis of colon cancer, surgery and chemotherapy, the original